Fisher J L, Zhang J, Macdonald R L
Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48104-1687, USA.
Mol Pharmacol. 1997 Oct;52(4):714-24. doi: 10.1124/mol.52.4.714.
The gamma-aminobutyric acidA (GABA) receptor in the mammalian central nervous system is composed of pentameric combinations of alpha1-6, beta1-4, gamma1-3, delta1, and/or epsilon1 subunit subtypes. Although each of the different subunits influences the functional properties of gamma-aminobutyric acidA receptors (GABARs), the alpha subunit subtypes have been shown to be important for activation of the receptor by GABA and pentobarbital and the regulation of GABARs by numerous allosteric regulators, including benzodiazepines, furosemide, zinc, and lanthanum. However, with the exception of the benzodiazepines, the alpha subtype domain that is responsible for the action of these allosteric compounds is unknown. The alpha1 and alpha6 subtypes are among the most diverse of the alpha subunit family and confer a different responsiveness of GABARs to GABA and many of the allosteric modulators. These regulatory compounds act after extracellular application and therefore likely act on extracellular GABAR sites, the largest of which is the amino-terminal extracellular domain. To determine the role of this domain in the action of these allosteric regulatory agents, we constructed chimeras of the rat alpha1 and alpha6 subtypes with a splice site within the first putative transmembrane domain (TM). This separated the large extracellular amino-terminal domain from the transmembrane, intracellular, and TM2-3 and carboxyl-terminal extracellular domains of the subunit. The chimeric subtypes were expressed in L929 fibroblasts along with beta3 and gamma2L subtypes, and their pharmacological properties were determined with whole-cell electrophysiological recording. The alpha subtype amino-terminal extracellular domain was the primary determinant of GABA sensitivity and was responsible for the functional properties of activation by pentobarbital, sensitivity to diazepam, potentiation by lanthanum, and high affinity inhibition by furosemide. The remaining carboxyl-terminal domains influenced the GABA sensitivity and determined zinc sensitivity and low affinity inhibition by furosemide. Both domains were apparently required for inhibition by lanthanum.
哺乳动物中枢神经系统中的γ-氨基丁酸A(GABA)受体由α1-6、β1-4、γ1-3、δ1和/或ε1亚基亚型的五聚体组合构成。尽管不同的亚基各自都会影响γ-氨基丁酸A受体(GABARs)的功能特性,但已证明α亚基亚型对于GABA和戊巴比妥激活受体以及众多变构调节剂(包括苯二氮䓬类、呋塞米、锌和镧)对GABARs的调节很重要。然而,除了苯二氮䓬类之外,负责这些变构化合物作用的α亚型结构域尚不清楚。α1和α6亚型是α亚基家族中差异最大的成员,赋予GABARs对GABA和许多变构调节剂不同的反应性。这些调节化合物在细胞外应用后起作用,因此可能作用于细胞外GABAR位点,其中最大的是氨基末端细胞外结构域。为了确定该结构域在这些变构调节因子作用中的作用,我们构建了大鼠α1和α6亚型的嵌合体,其剪接位点位于第一个假定的跨膜结构域(TM)内。这将大的细胞外氨基末端结构域与亚基的跨膜、细胞内、TM2-3和羧基末端细胞外结构域分开。嵌合亚型与β3和γ2L亚型一起在L929成纤维细胞中表达,并用全细胞膜片钳电生理记录来确定它们的药理学特性。α亚型氨基末端细胞外结构域是GABA敏感性的主要决定因素,并负责戊巴比妥激活的功能特性、对地西泮的敏感性、镧的增强作用以及呋塞米的高亲和力抑制作用。其余的羧基末端结构域影响GABA敏感性,并决定锌敏感性和呋塞米的低亲和力抑制作用。镧的抑制作用显然需要这两个结构域。